Stock listing

OTC:OTCFF Ocumetics Technology Corp Stock

US listing (OTC) of Ocumetics Technology Corp · home listing TSXV:OTC

Follow Ocumetics Technology Corp into a list and get an email when it puts out news.

Share price · OTC:OTCFF

$0.27 USD +0.01 (+4.0%)

Close on Nov 19, 2026

Past year -58.6% · daily closes, Nov 19, 2025 – Nov 6, 2026, adjusted for splits
Day range
$0.267 – $0.27 USDNov 19, 2026
Volume
9,000 sharesNov 19, 2026
Market cap
$36.31M USDAt the close on Nov 19, 2026 · price × 134.4M shares outstanding
52-week range
$0.26 – $0.672 USDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
$1,908 USDMedian day 1,260 shares · 24 days with no trades · last 3 months, Aug 19, 2026 – Nov 6, 2026
Ocumetics Technology Corp logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TSXV:OTC · Home$0.38 CAD+0.01 (+2.7%)29,809$0.375$0.38$0.37$0.37Close on Nov 20, 2026
OTC:OTCFF$0.27 USD+0.01 (+4.0%)9,000$0.267$0.27$0.267$0.26Close on Nov 19, 2026
Frankfurt:2QB0€0.19 EUR0.00 (0.0%)—€0.19€0.19€0.19€0.19Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 19, 2026 – Nov 6, 2026 · OTC:OTCFF · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.28-0.051-15.5%$0.28$0.28$0.2814,000
$0.3310.000.0%$0.331$0.331$0.3310
$0.331+0.042+14.6%$0.289$0.331$0.2894,246
$0.2890.000.0%$0.289$0.289$0.2890
$0.289+0.004+1.3%$0.288$0.30$0.28842,400
$0.285+0.001+0.2%$0.285$0.285$0.28515,648
$0.285+0.009+3.3%$0.276$0.285$0.27638,210
$0.276-0.005-1.6%$0.276$0.284$0.27639,569
$0.280.000.0%$0.28$0.28$0.289,500
$0.280.000.0%$0.28$0.28$0.280
$0.280.000.0%$0.28$0.28$0.280
$0.280.000.0%$0.28$0.28$0.280
$0.280.000.0%$0.28$0.28$0.280
$0.28+0.003+0.9%$0.28$0.28$0.281,000
$0.2780.000.0%$0.278$0.278$0.2780
$0.2780.000.0%$0.278$0.278$0.2780
$0.278-0.027-9.0%$0.284$0.284$0.27810,600
$0.3050.000.0%$0.305$0.305$0.3050
$0.3050.000.0%$0.305$0.305$0.3050
$0.305+0.005+1.6%$0.305$0.305$0.3055,000
$0.30+0.015+5.2%$0.302$0.302$0.3015,400
$0.2850.000.0%$0.285$0.285$0.2850
$0.285-0.013-4.4%$0.30$0.30$0.28520,250
$0.299-0.013-4.1%$0.278$0.299$0.2783,777
$0.3110.000.0%$0.311$0.311$0.31118,500
$0.3110.000.0%$0.311$0.311$0.3110
$0.311-0.009-2.7%$0.325$0.325$0.31110,000
$0.320.000.0%$0.32$0.32$0.320
$0.32+0.01+3.2%$0.32$0.32$0.324,600
$0.31+0.01+3.2%$0.31$0.31$0.31113
$0.30-0.099-24.8%$0.40$0.40$0.3012,755
$0.400.000.0%$0.40$0.40$0.400
$0.40+0.05+14.1%$0.40$0.40$0.404,700
$0.350.000.0%$0.35$0.35$0.350
$0.35+0.022+6.6%$0.35$0.35$0.359,000
$0.328+0.008+2.6%$0.34$0.34$0.32820,000
$0.320.000.0%$0.32$0.32$0.320
$0.320.000.0%$0.32$0.32$0.320
$0.320.000.0%$0.32$0.32$0.320
$0.32-0.008-2.5%$0.31$0.32$0.30812,000
$0.328-0.022-6.3%$0.328$0.328$0.3285,000
$0.35+0.003+0.9%$0.35$0.35$0.35800
$0.347-0.029-7.6%$0.364$0.364$0.3474,673
$0.376+0.055+17.3%$0.36$0.376$0.365,600
$0.320.000.0%$0.36$0.36$0.321,000
$0.320.000.0%$0.32$0.32$0.320
$0.320.000.0%$0.32$0.32$0.320
$0.32+0.04+14.2%$0.331$0.331$0.3211,500
$0.28-0.119-29.9%$0.28$0.28$0.286,666
$0.40+0.078+24.3%$0.40$0.40$0.409,620
$0.322-0.058-15.4%$0.322$0.322$0.3223,500
$0.380.000.0%$0.38$0.38$0.380
$0.380.000.0%$0.38$0.38$0.380
$0.38+0.076+25.0%$0.38$0.38$0.38250
$0.3040.000.0%$0.304$0.304$0.3040
$0.304-0.006-2.0%$0.40$0.40$0.3011,520
$0.310.000.0%$0.31$0.31$0.310
$0.310.000.0%$0.31$0.31$0.314,000
Ticker
OTC:OTCFF
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Ocumetics Technology Corp news

Ocumetics Technology Corp on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
26 in the last 12 months · 92 in all · newest Nov 12, 2026 · oldest 2021
Decks
9 decks · latest November 2026

Where Ocumetics Technology Corp is listed

ListingExchangeCountryCurrency
TSXV:OTC · Home listingTSXVCanadaCAD
OTC:OTCFF · This pageOTCUnited StatesUSD
Cboe Canada:OTCCboe CanadaCanadaCAD
Frankfurt:2QB0FrankfurtGermanyEUR

Valuation

Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$53.93M CAD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta vs S&P/TSX Composite
0.14

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Ocumetics Technology Corp · TSXV:OTCUS$37.38MUS$37.60Mn/an/an/an/an/an/a0.14
electroCore, Inc. · NASDAQ:ECORUS$40.78MUS$41.51Mn/a1.1×n/an/a−33.5%n/a1.91
Elutia, Inc. · NASDAQ:ELUTUS$39.86MUS$18.87M0.7×1.5×n/a2.6×441.2%0.5×-0.06
DRGEM Corp. · KRX:263690US$38.81MUS$32.33M4.3×0.4×3.2×0.5×11.2%0.1×n/a
Cryofocus Medtech (Shanghai) Co. Ltd. Class H · HKEX:6922US$37.93MUS$29.03Mn/a2.0×n/a3.8×−40.1%0.0×n/a
Optomed Oyj Class A · OMXHEX:OPTOMEDUS$37.24MUS$32.48Mn/a1.8×n/a1.6×−33.9%0.1×n/a
Sensus Healthcare, Inc. · NASDAQ:SRTSUS$37.20MUS$24.56Mn/a1.5×n/a1.1×−96.5%0.0×1.08
Epiminder Ltd. · ASX:EPIUS$36.57M−US$13.60Mn/an/an/a0.7×n/a0.0×n/a
Avita Corporation · TPEX:4735US$35.63MUS$14.80M5.1×0.5×4.4×1.0×23.8%0.0×n/a
SELVAS Healthcare, Inc. · KRX:208370US$35.56MUS$15.07M5.5×0.6×8.0×0.6×27.5%0.0×n/a
Taiwan Biomaterial Co., Ltd. · TPEX:6649US$35.55MUS$28.06M35.3×5.1×26.5×1.8×18.2%0.0×n/a
Median of the othersUS$37.22MUS$26.31M5.1×1.5×6.2×1.1×11.2%0.0×1.08

Team and board

Officers

OfficerRole
Dean E. BurnsPRESIDENT / CEO / DIRECTOR
Roger JewettCFO / DIRECTOR
David BurwellDirector, Investor Relations
Doyle StultingChief Medical Officer
GARTH WEBBFOUNDER / CSO / DIRECTOR

Board

DirectorRole
Dean E. BurnsPRESIDENT / CEO / DIRECTOR
GARTH WEBBFOUNDER / CSO / DIRECTOR
James Barton McRobertsDIRECTOR
Michael EdwardsDIRECTOR
Raymond MarksDIRECTOR
Robert QuinnDIRECTOR
Roger JewettCFO / DIRECTOR
Sandi GilbertDirector

Events

Next results
Nov 24, 2026 (expected)

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck37 slidesNovember 2026
Investor Presentation (March 2026)Investor deck37 slidesMarch 2026
Investor Presentation (March 2026)Investor deck22 slidesMarch 2026
Investor Presentation (November 2025)Investor deck36 slidesNovember 2025
Investor Presentation (November 2025)Investor deck19 slidesNovember 2025
Investor Presentation (June 2025)Investor deck36 slidesJune 2025
Investor Presentation (March 2025)Investor deck36 slidesMarch 2025
Investor Presentation (July 2024)Investor deck36 slidesJuly 2024
Investor Presentation (September 2023)Investor deck36 slidesSeptember 2023

Open Decks

Financings

RaiseDateIn US dollars
Private placement of units
Closed: C$3.11M raised · C$0.4 a unit · 1 warrant at C$0.5 for 36 months · Ventum Financial Corp. +1
Dealers: Ventum Financial Corp. (finder), Canaccord Genuity Corp. (finder)
Use of proceeds: First-in-human clinical trials, ongoing research and development and general working capital
Aug 24, 2026
Not stated
Update: raise
Use of proceeds: Fund completion of the first-in-human clinical study and support manufacturing, regulatory and commercialization activities
Jul 9, 2026
Private placement of units
Announced: up to C$1.54M · C$0.55 a unit · 1 warrant at C$0.75 for 36 months
Use of proceeds: First in-human clinical trials, ongoing research and development, and general working capital
Apr 29, 2026US$1.13M
Private placement of units
Closed: C$1.02M raised · C$0.6 a unit · 1 warrant at C$0.75 for 36 months · Centurion One Capital Corp.
Dealers: Centurion One Capital Corp. (lead)
Buyers: Dean Burns; Roger Jewett; Garth Webb; Doyle Stulting; J. Barton McRoberts; Michael Edwards
Insiders: Directors Dean Burns (CEO), Roger Jewett (CFO), Garth Webb, Doyle Stulting, J. Barton McRoberts and Michael Edwards participated; related party transaction under MI 61-101
Use of proceeds: First-in-human clinical trials, ongoing research and development and general corporate purposes
Feb 10, 2026
Private placement of units
Tranche closed: C$235,450 raised · C$0.6 a unit · Warrants at C$0.75 · Centurion One Capital Corp.
Dealers: Centurion One Capital Corp.
Jan 2, 2026US$171,398
Private placement of units
Closed: C$1.12M raised · C$0.35 a unit · ½ warrant at C$0.5 for 24 months · Numus Capital Corp.
Dealers: Numus Capital Corp.
Buyers: Michael Edwards
Insiders: Michael Edwards, a director of the Corporation, participated in the Private Placement.
Use of proceeds: Ongoing research and development
Aug 12, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in CAD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue000000
Research and development1.42M852.4K907.4K555.7K0
Selling, general and administrative2.32M1.31M2.49M1.45M514.7K99.4K
Operating income-4.00M-2.43M-3.61M-2.18M-598.2K-172.5K
Depreciation and amortization149.4K134.3K117.6K102.2K83.5K73.1K66.8K60.6K
EBITDA-3.85M-2.29M-3.49M-2.08M-514.7K-99.4K
Interest expense1.35M639.1K29.3K26.6K0000
Income before tax-5.37M-3.06M-3.64M-2.22M-598.2K-172.5K
Net income-5.37M-3.02M-3.64M-2.22M-598.2K-172.5K
Earnings per share, basic-0.04-0.03-0.03-0.02-0.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents464.0K195.2K235.8K602.1K83.9K
Short-term investments01.38M0
Receivables01.27K28.7K5475332.35K
Current assets1.25M1.65M311.0K673.0K112.6K1.39K2.19K3.00K
Total assets1.90M2.32M1.04M1.37M825.3K
Accounts payable472.4K229.4K546.9K167.4K55.2K33.7K3.90K7.63K
Current liabilities5.46M306.2K623.7K244.1K644.2K142.0K559.9K462.9K
Long-term debt389.4K3.95M321.6K292.3K
Total liabilities5.85M4.26M945.3K536.5K1.10M
Shareholders' equity-3.94M-1.94M91.1K837.4K-270.5K
Shares outstanding129.2M119.8M118.5M111.2M108.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-3.37M-2.43M-2.05M-1.62M-89.1K-8171.01K-47.8K
Capital spending-126.1K-84.9K-142.2K-66.8K-124.5K000
Free cash flow-3.49M-2.51M-2.19M-1.69M-213.6K-8171.01K-47.8K
Cash from investing-214.9K-214.9K-214.9K-214.9K
Cash from financing2.38M3.85M1.82M444.4K387.1K387.1K387.1K387.1K
Change in cash268.9K-40.6K-366.3K-1.24M83.1K-8171.01K-47.8K

Open Financials

Cap table

Built by 6ix from Ocumetics Technology Corp’s releases · as of Aug 24, 2026

Common shares
141,067,106
Fully diluted
145,299,520

Fully diluted

LineSharesAs of
Common shares141,067,106Aug 24, 2026
Warrants4,232,414Jul 31, 2026

Warrants and options

Lot
Warrants · C$0.50 · expire about Jul 2029
Warrants · C$0.75 · expire about Dec 2028
Warrants · C$0.50 · expire about Jul 2027
Broker warrants · expiry not stated
Broker warrants · expiry not stated

Share count over time

CountShares
Aug 24, 2026141,067,106
Jul 31, 2026140,662,106
Jun 30, 2026134,412,106

Open Cap table

Shareholders

TradeTradeSharesPriceValueDate
Garth Thomas Webb
10% Security Holder of Issuer
Option exercise1,143,950CAD 0.13CAD 143KAug 26, 2026
Garth Thomas Webb
10% Security Holder of Issuer
Option exercise1,143,950CAD 0.13CAD 143KAug 26, 2026
Robert Joseph J.D. Quinn
Director of Issuer
Option exercise541,317CAD 0.13CAD 67,665Aug 21, 2026
Michael Lee Edwards
Director of Issuer
Placement50,000CAD 0.40CAD 20,000Jul 28, 2026
Roger Myles Jewett
Director of Issuer
Buy2,000CAD 0.54CAD 1,080May 10, 2026
Roger Myles Jewett
Director of Issuer
Buy10,000CAD 0.54CAD 5,400May 8, 2026
Roger Myles Jewett
Director of Issuer
Buy1,000CAD 0.57CAD 570May 4, 2026
Roger Myles Jewett
Director of Issuer
Buy1,000CAD 0.56CAD 560May 1, 2026
Roger Myles Jewett
Director of Issuer
Buy20,000CAD 0.48CAD 9,700Apr 10, 2026
Roger Myles Jewett
Director of Issuer
Buy10,000CAD 0.48CAD 4,800Apr 8, 2026
All 22 trades
TradeTradeSharesPriceValueDate
Roger Myles Jewett
Director of Issuer
Buy10,000CAD 0.47CAD 4,700Apr 8, 2026
Roger Myles Jewett
Director of Issuer
Buy10,000CAD 0.46CAD 4,550Apr 7, 2026
James Barton McRoberts
Director of Issuer
Award174,000CAD 0.37CAD 64,380Apr 4, 2026
Michael Lee Edwards
Director of Issuer
Award174,000CAD 0.37CAD 64,380Mar 31, 2026
Raymond Marks
Director of Issuer
Award325,000CAD 0.37CAD 120KMar 31, 2026
Roger Myles Jewett
Director of Issuer
Award1,300,000CAD 0.37CAD 481KMar 31, 2026
Roger Myles Jewett
Director of Issuer
Placement25,000CAD 0.60CAD 15,000Jan 2, 2026
Garth Thomas Webb
10% Security Holder of Issuer
Placement15,750CAD 0.60CAD 9,450Jan 2, 2026
James Barton McRoberts
Director of Issuer
Placement16,667CAD 0.60CAD 10,000Jan 2, 2026
Robert Doyle Stulting
Director of Issuer
Placement23,333CAD 0.60CAD 14,000Dec 30, 2025
Michael Lee Edwards
Director of Issuer
Placement33,333CAD 0.60CAD 20,000Dec 30, 2025
Dean E Burns
Senior Officer of Issuer
Buy23,333CAD 0.60CAD 14,000Dec 30, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David BurwellDirector, Investor Relations · Since at least Oct 29, 2026
Dean BurnsPRESIDENT / CEO / DIRECTOR · Since at least Oct 29, 2026
Doyle StultingChief Medical Officer · Since at least Jan 9, 2026
Garth WebbFOUNDER / CSO / DIRECTOR · Since at least Aug 31, 2026
James Barton McRobertsDIRECTOR · Since at least Nov 5, 2026
Michael L. EdwardsDIRECTOR · Since at least Mar 11, 2025
Raymond MarksDIRECTOR · Since at least Feb 24, 2026
Robert QuinnDIRECTOR · Since at least Nov 5, 2026
Roger JewettCFO / DIRECTOR · Since at least Sep 12, 2025
Sandi GilbertDirector · Since at least Oct 29, 2026

Open People

Log in to ask 6ix AI your own questions about Ocumetics Technology Corp.